2-Chloro-4-{[(4-methylphenyl)sulfonyl]azamethylene}naphthalen-1-one → (NE)-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]-4-phenylbenzenesulfonamide

Participants

Role	Name	HCID	Charge
Reactant	2-Chloro-4-{[(4-methylphenyl)sulfonyl]azamethylene}naphthalen-1-one	HCID 5717988	—
Reactant	(NE)-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]-4-phenylbenzenesulfonamide	HCID 46908285	—
Product	(NE)-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]-4-phenylbenzenesulfonamide	HCID 46908285	96.1%
Product	(NE)-4-methyl-N-[3-(1-methyltetrazol-5-yl)sulfanyl-4-oxonaphthalen-1-ylidene]benzenesulfonamide	HCID 46908381	—

Reaction Steps

(E)-4-methyl-N-(3-(1-methyl-1H-tetrazol-5-ylthio)-4-oxonaphthalen-1(4H)-ylidene)benzenesulfonamide (13ad) was prepared according to the procedure for 13x except using 12i, affording 81.8 mg (96.1%) title compound as a yellow solid.

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US08466157B2
Source dataset	uspto-grants-2013_06
ORD ID	ord-713f6926dd0d46958c812e07fea92160
Source note	uspto-grants-2013_06